The in vivo cell therapy seed Carisma Therapeutics planted with Moderna in 2022 is starting to sprout. | The in vivo cell ...

Brenus Pharma has announced the publication of a scientific article describing its new "off-the-shelf" cancer treatment in ...

Researchers have developed an innovative CAR T-cell therapy to combat glioblastoma, the most common malignant brain tumor in ...

Glioblastoma is the most common kind of malignant brain tumor in adults. So far, no treatment has been able to make this ...

When thinking about the immune system, most people think about B and T cells and how they can be trained to recognize ...

Stem cells provide new insights into cardiovascular disease, helping researchers understand its causes and identify potential ...

As the science stands, the vast majority of the roughly eight million people in South Africa living with HIV will have to get ...

Researchers at Tel Aviv University (TAU) can add to that list their important discovery of a cancer mechanism that has been ...

When thinking about the immune system, most people think about B and T cells and how they can be trained to recognize pathogens, preventing re-infections.